Journal
Transplantation and Cellular Therapy
Publication Date
11-1-2024
Volume
30
Issue
11
First Page
1065
Last Page
1079
Document Type
Open Access Publication
DOI
10.1016/j.jtct.2024.08.018
Rights and Permissions
Locke FL, Neelapu SS, Bartlett NL, Lekakis LJ, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Kersten MJ, Zheng Y, Zhang T, Nater J, Shen R, Miao H, Kim JJ, Miklos DB. Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma. Transplant Cell Ther. 2024 Nov;30(11):1065-1079. doi: 10.1016/j.jtct.2024.08.018. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Locke, Frederick L; Bartlett, Nancy L; and et al., "Tocilizumab prophylaxis following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma." Transplantation and Cellular Therapy. 30, 11. 1065 - 1079. (2024).
https://digitalcommons.wustl.edu/oa_4/5612
Additional Links
Supplemental material is available for this article at publisher site.
